| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |